Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids

被引:359
作者
Lee, WJ
Shim, JY
Zhu, BT
机构
[1] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC 29208 USA
[2] N Carolina Cent Univ, Biomed Biotechnol Res Inst, Durham, NC USA
关键词
D O I
10.1124/mol.104.008367
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present investigation, we studied the modulating effects of several tea catechins and bioflavonoids on DNA methylation catalyzed by prokaryotic SssI DNA methyltransferase (DNMT) and human DNMT1. We found that each of the tea polyphenols [ catechin, epicatechin, and (-)-epigallocatechin-3-O-gallate (EGCG)] and bioflavonoids (quercetin, fisetin, and myricetin) inhibited SssI DNMT- and DNMT1-mediated DNA methylation in a concentration-dependent manner. The IC50 values for catechin, epicatechin, and various flavonoids ranged from 1.0 to 8.4 mu M, but EGCG was a more potent inhibitor, with IC50 values ranging from 0.21 to 0.47 mu M. When epicatechin was used as a model inhibitor, kinetic analyses showed that this catechol-containing dietary polyphenol inhibited enzymatic DNA methylation in vitro largely by increasing the formation of S-adenosyl-L-homocysteine (a potent noncompetitive inhibitor of DNMTs) during the catechol-O-methyltransferase-mediated O-methylation of this dietary catechol. In comparison, the strong inhibitory effect of EGCG on DNMT- mediated DNA methylation was independent of its own methylation and was largely due to its direct inhibition of the DNMTs. This inhibition is strongly enhanced by Mg2+. Computational modeling studies showed that the gallic acid moiety of EGCG plays a crucial role in its high-affinity, direct inhibitory interaction with the catalytic site of the human DNMT1, and its binding with the enzyme is stabilized by Mg2+. The modeling data on the precise molecular mode of EGCG's inhibitory interaction with human DNMT1 agrees perfectly with our experimental finding.
引用
收藏
页码:1018 / 1030
页数:13
相关论文
共 39 条
  • [21] SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold
    Martin, JL
    McMillan, FM
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (06) : 783 - 793
  • [22] Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
    Okano, M
    Xie, SP
    Li, E
    [J]. NATURE GENETICS, 1998, 19 (03) : 219 - 220
  • [23] Palmisano WA, 2000, CANCER RES, V60, P5954
  • [24] PRESS WH, 1993, NUMERICAL RECIPES AR, P420
  • [25] CLONING, CHARACTERIZATION, AND EXPRESSION IN ESCHERICHIA-COLI OF THE GENE CODING FOR THE CPG DNA METHYLASE FROM SPIROPLASMA SP STRAIN MQ1(M.SSSL)
    RENBAUM, P
    ABRAHAMOVE, D
    FAINSOD, A
    WILSON, GG
    ROTTEM, S
    RAZIN, A
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (05) : 1145 - 1152
  • [26] Saunders N, 1999, CANCER RES, V59, P399
  • [27] Many paths to methyltransfer: a chronicle of convergence
    Schubert, HL
    Blumenthal, RM
    Cheng, XD
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (06) : 329 - 335
  • [28] Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells
    Shaker, S
    Bernstein, M
    Momparler, LF
    Momparler, RL
    [J]. LEUKEMIA RESEARCH, 2003, 27 (05) : 437 - 444
  • [29] Shi HD, 2003, CANCER RES, V63, P2164
  • [30] Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells
    Sirchia, SM
    Ferguson, AT
    Sironi, E
    Subramanyan, S
    Orlandi, R
    Sukumar, S
    Sacchi, N
    [J]. ONCOGENE, 2000, 19 (12) : 1556 - 1563